This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

An Effect on Head and Neck Squamous Carcinoma Cultures

William J. Richtsmeier, MD, PhD

Arch Otolaryngol Head Neck Surg. 1988;114(4):432-437.

Abstract
• We have measured an oncolytic effect of recombinant human interferon gamma on squamous cell carcinoma (SCC) tissue cultures. The decrease in viable cells from an established culture was visually observed directly and measured by the loss of cell protein mass as determined by the staining of cultures with naphthol blue-black dye. We avoided confusion with tumor necrosis factor effects by using recombinant human interferon gamma cloned from a single gene as opposed to natural human interferon gamma. Oncolysis induced by recombinant human interferon gamma requires four days after exposure for a significant loss of total cellular protein to be measured, although changes can be observed visually after one day. This sensitivity to recombinant human interferon gamma was observed in SCC cultures obtained from head and neck mucosa, in addition to those from cervix and skin. Several head and neck cultures are sensitive to the oncolytic effect of recombinant human interferon gamma at less than 30 U/mL concentration. The actual time of treatment observations dictates changes in current recombinant human interferon gamma treatment regimens if the oncolytic effect is desired.

(Arch Otolaryngol Head Neck Surg 1988;114:432-437)

Author Affiliations
From The Johns Hopkins Medical Institutions, Baltimore.

Footnotes
Accepted for publication Dec 14, 1987.

Read before the annual meeting of the American Society for Head and Neck Surgery, Denver, April 29, 1987.

Reprint requests to The Johns Hopkins Medical Institutions, 600 N Wolfe St, Carnegie 469, Baltimore, MD 21205 (Dr Richtsmeier).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interferon Gamma Enhances Lymphokine-Activated Killer Cell Adhesion but Not Lysis of Head and Neck Squamous Cell Carcinoma
Scher et al.
Arch Otolaryngol Head Neck Surg 1995;121:1271-1275.
ABSTRACT  

Growth Inhibition by Interferon Beta and Gamma of MDA 886Ln Monolayer Cells and Multicellular Tumor Spheroids: A Differentiation Therapy Model for Squamous Cell Carcinoma
Sacks et al.
Arch Otolaryngol Head Neck Surg 1994;120:1267-1272.
ABSTRACT  

Induction of the Intercellular Adhesion Molecule (ICAM-1) on Squamous Cell Carcinoma by Interferon Gamma
Scher et al.
Arch Otolaryngol Head Neck Surg 1993;119:432-438.
ABSTRACT  

Tumor Necrosis Factor and Chemotherapeutic Agents: Potentiation of Cytotoxicity With Interferon Gamma
Dawson et al.
Arch Otolaryngol Head Neck Surg 1992;118:1168-1171.
ABSTRACT  

Phase I-II Study of Advanced Head and Neck Squamous Cell Carcinoma Patients Treated With Recombinant Human Interferon Gamma
Richtsmeier et al.
Arch Otolaryngol Head Neck Surg 1990;116:1271-1277.
ABSTRACT